In the News

The study represents 20 years of research at MSK.

Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.

MSK's Neil Iyengar will present at the American Association for Cancer Research special conference about the risk of invasive breast cancer. A new study found that the risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat. These findings suggest that having a normal BMI can provide false reassurance regarding the risk of breast cancer associated with body fat, and they also highlight the potential role of physical activity and exercise even in those who are at a normal weight. For expert interviews, please contact Nicole H. McNamara at [email protected].

The online resource will serve as a benchmark for researchers studying metabolism and cancer.

MSK's new clinic will focus on clonal hematopoiesis, a condition related to aging that increases the risk of developing certain blood cancers.

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

Carl Granum tells the story of his diagnosis and treatment for a desmoplastic small round cell tumor, a type of sarcoma that typically begins in the abdomen or pelvis.

The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.

Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.

Learn how MSK nurse practitioner Mindy Jaffe guides children and young adults with cancer and their families through their reproductive options.